1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 13 Hits
  • 検索条件 : 絞込み (MeSH = Naphthoquinones / pharmacology*)
生物種 リソース名 タイトル
ヒト・動物細胞 Hep G2(RCB0459) Comparison of the cytotoxic activities of naturally occurring hydroxyanthraquinones and hydroxynaphthoquinones.
ヒト・動物細胞 HeLa(RCB0007) New 2-aryl-1,4-naphthoquinone-1-oxime methyl ether compound induces microtubule depolymerization and subsequent apoptosis.
ヒト・動物細胞 MH7A(RCB1512) Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways.
ヒト・動物細胞 MDCK(RCB0995) Nanaomycin K, a new epithelial-mesenchymal transition inhibitor produced by the actinomycete "Streptomyces rosa subsp. notoensis" OS-3966.
ヒト・動物細胞 HCT116(RCB2979) , HL-60 Synthetic and Biological Studies of Juglorubin and Related Naphthoquinones.
ヒト・動物細胞 B16 melanoma(RCB1283) Mansonone E from Mansonia gagei Inhibited α-MSH-Induced Melanogenesis in B16 Cells by Inhibiting CREB Expression and Phosphorylation in the PI3K/Akt Pathway.
ヒト・動物細胞 MDCK(RCB0995) Canine squamous cell carcinoma cell lines with high expression of survivin are sensitive to survivin inhibitor YM155.
ヒト・動物細胞 HeLa(RCB0007) , A549(RCB0098) Furanonaphthoquinones cause apoptosis of cancer cells by inducing the production of reactive oxygen species by the mitochondrial voltage-dependent anion channel.
ヒト・動物細胞 A549(RCB0098) Mitochondrial damage prior to apoptosis in furanonaphthoquinone treated lung cancer cells.
ヒト・動物細胞 WI-38(RCB0702) Structural injury of osteosarcoma mitochondria by a novel antitumour agent, 2-methylfuranonaphthoquinone.
ヒト・動物細胞 HSC-4(RCB1902) , HSC-2(RCB1945) , HSC-3(RCB1975) , HL60(RCB0041) Tumor-specific cytotoxicity and type of cell death induced by naphtho[2,3-b]furan-4,9-diones and related compounds in human tumor cell lines: relationship to electronic structure.
遺伝子材料 hTRAIL/pMKITneo (RDB02934) YM155 sensitizes triple-negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulation.
ヒト・動物細胞 SCCTF(RCB0442) , SCCKN(RCB0441) Furanonaphthoquinone analogs possessing preferential antitumor activity compared to normal cells.